{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T08:08:21Z","timestamp":1792656501707,"version":"4.5.0"},"reference-count":76,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jcehepatology.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical and Experimental Hepatology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/j.jceh.2014.03.049","type":"journal-article","created":{"date-parts":[[2014,3,31]],"date-time":"2014-03-31T08:45:51Z","timestamp":1396255551000},"page":"S130-S139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"special_numbering":"S3","title":["Role of Supportive Care for Terminal Stage Hepatocellular Carcinoma"],"prefix":"10.1016","volume":"4","author":[{"given":"Manoj","family":"Kumar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dipanjan","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jceh.2014.03.049_bib1","first-page":"190","article-title":"Cancer incidence, mortality, and associated risk factors among Asian Americans of Chinese, Filipino, Vietnamese, Korean, and Japanese ethnicities","volume":"57","author":"McCracken","year":"2007","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.jceh.2014.03.049_bib2","series-title":"Liver Cancer","first-page":"13","article-title":"Global epidemiology of hepatocellular carcinoma","author":"Bosch","year":"1997"},{"key":"10.1016\/j.jceh.2014.03.049_bib3","unstructured":"Annual Report 1987. National Cancer Registry Programme. New Delhi, Indian Council of Medical Research, 1990."},{"key":"10.1016\/j.jceh.2014.03.049_bib4","series-title":"Rural cancer registry at Barshi-report 1988\u201392","author":"Jayant","year":"1994"},{"key":"10.1016\/j.jceh.2014.03.049_bib5","series-title":"Hepatitis B and C. Carrier to Cancer","first-page":"268","article-title":"Hepatocellular carcinoma in Asia","author":"Park","year":"2002"},{"key":"10.1016\/j.jceh.2014.03.049_bib6","series-title":"Hepatitis B and C. Carrier to Cancer","first-page":"363","article-title":"Hepatocellular carcinoma in Asia","author":"Pyrsopoulos","year":"2002"},{"issue":"2","key":"10.1016\/j.jceh.2014.03.049_bib7","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ijc.27993","article-title":"Aetiological and molecular profile of hepatocellular cancer from India","volume":"133","author":"Asim","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1159\/000231886","article-title":"Clinical profile, etiology and therapeutic outcome in 324 hepatocellular carcinoma patients at a tertiary care center in India","volume":"77","author":"Paul","year":"2009","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2014.03.049_bib9","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1093\/qjmed\/hcn033","article-title":"Characteristics of hepatocellular carcinoma in India: a retrospective analysis of 191 cases","volume":"101","author":"Kumar","year":"2008","journal-title":"QJM"},{"key":"10.1016\/j.jceh.2014.03.049_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1111\/j.1440-1746.2007.04908.x","article-title":"Risk factors analysis for hepatocellular carcinoma in patients with and without cirrhosis: a case-control study of 213 hepatocellular carcinoma patients from India","volume":"22","author":"Kumar","year":"2007","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1016\/j.jceh.2014.03.049_bib11","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1081\/CNV-120018233","article-title":"Hepatocellular carcinoma: are we making progress?","volume":"21","author":"Zhu","year":"2003","journal-title":"Cancer Invest"},{"key":"10.1016\/j.jceh.2014.03.049_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1016\/j.jhep.2011.12.001","article-title":"EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma","volume":"56","author":"European Association for the Study of the Liver","year":"2012","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.jceh.2014.03.049_bib13","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1055\/s-2007-1007122","article-title":"Prognosis of hepatocellular carcinoma: the BCLC staging classification","volume":"19","author":"Llovet","year":"1999","journal-title":"Semin Liver Dis"},{"issue":"4","key":"10.1016\/j.jceh.2014.03.049_bib14","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4254\/wjh.v4.i9.256","article-title":"Natural history of untreatable hepatocellular carcinoma: a retrospective cohort study","volume":"27","author":"Cabibbo","year":"2012","journal-title":"World J Hepatol"},{"key":"10.1016\/j.jceh.2014.03.049_bib15","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23485","article-title":"A\u00a0meta-analysis of survival rates of untreated patients in randomized clinical trials of hepatocellular carcinoma","volume":"51","author":"Cabibbo","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.049_bib16","unstructured":"http:\/\/www.who.int\/cancer\/palliative\/definition\/en\/. Accessed 19.12.12."},{"key":"10.1016\/j.jceh.2014.03.049_bib17","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1191\/0269216304pm851oa","article-title":"Hospice palliative care for patients with hepatocellular carcinoma in Taiwan","volume":"18","author":"Lin","year":"2004","journal-title":"Palliat Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib18","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/1099-1611(200101\/02)10:1<19::AID-PON501>3.0.CO;2-6","article-title":"The prevalence of psychological distress by cancer site","volume":"10","author":"Zabora","year":"2001","journal-title":"Psychooncology"},{"key":"10.1016\/j.jceh.2014.03.049_bib19","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1097\/00002820-200507000-00005","article-title":"Symptom clusters: concept analysis and clinical implications for cancer nursing","volume":"28","author":"Kim","year":"2005","journal-title":"Cancer Nurs"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.049_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/NCC.0b013e3181b4367e","article-title":"Symptom clusters and quality of life in Korean patients with hepatocellular carcinoma","volume":"33","author":"Ryu","year":"2010","journal-title":"Cancer Nurs"},{"key":"10.1016\/j.jceh.2014.03.049_bib21","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/jncimonographs\/lgh023","article-title":"Symptom clusters: the new frontier in symptom management research","volume":"32","author":"Miaskowski","year":"2004","journal-title":"J\u00a0Natl Cancer Inst Monographs"},{"key":"10.1016\/j.jceh.2014.03.049_bib22","series-title":"Gastrointestinal Symptoms in Advanced cancer Patients","first-page":"223","article-title":"Abdominal pain","author":"Mercadante","year":"2002"},{"key":"10.1016\/j.jceh.2014.03.049_bib23","unstructured":"Hamilton J, Runyon B, Bonis P, et\u00a0al. Management of pain in patients with cirrhosis. uptodateonline.com. http:\/\/uptodateonline.com\/online\/content\/topic.do?topicKey=cirrhosi\/11256&selectedTitle =1\u223c150&source=search result. Updated May 21, 2009."},{"key":"10.1016\/j.jceh.2014.03.049_bib24","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1002\/hep.20595","article-title":"Effects of celecoxib and naproxen on renal function in nonazotemic patients with cirrhosis and ascites","volume":"41","author":"Cl\u00e0ria","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.049_bib25","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/BF00558076","article-title":"Hepatic extraction of morphine is impaired in cirrhosis","volume":"36","author":"Crotty","year":"1989","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.jceh.2014.03.049_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1365-2125.1990.tb03638.x","article-title":"The metabolism and bioavailability of morphine in patients with severe liver cirrhosis","volume":"29","author":"Hasselstr\u00f6m","year":"1990","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/j.jceh.2014.03.049_bib27","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1213\/00000539-198704000-00001","article-title":"Pharmacokinetics of unchanged morphine in normal and cirrhotic subjects","volume":"66","author":"Mazoit","year":"1987","journal-title":"Anesth Analg"},{"key":"10.1016\/j.jceh.2014.03.049_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1002\/cpt1974164667","article-title":"The effect of cirrhosis on the disposition and elimination of meperidine in man","volume":"16","author":"Klotz","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1038\/clpt.1981.146","article-title":"Presystemic metabolism of meperidine to normeperidine in normal and cirrhotic subjects","volume":"30","author":"Pond","year":"1981","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib30","doi-asserted-by":"crossref","first-page":"451","DOI":"10.4065\/mcp.2009.0534","article-title":"Pain management in the cirrhotic patient: the clinical challenge","volume":"85","author":"Chandok","year":"2010","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jceh.2014.03.049_bib31","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2165\/00003088-199937010-00002","article-title":"Pharmacokinetics of opioids in liver disease","volume":"37","author":"Tegeder","year":"1999","journal-title":"Clin Pharm"},{"key":"10.1016\/j.jceh.2014.03.049_bib32","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1093\/bja\/54.12.1267","article-title":"Fentanyl pharmacokinetics in anaesthetized patients with cirrhosis","volume":"54","author":"Haberer","year":"1982","journal-title":"Br J Anaesth"},{"key":"10.1016\/j.jceh.2014.03.049_bib33","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1530-0277.1985.tb05558.x","article-title":"Effect of severe alcoholic liver disease on the disposition of methadone in maintenance patients","volume":"9","author":"Novick","year":"1985","journal-title":"Alcohol Clin Exp Res"},{"key":"10.1016\/j.jceh.2014.03.049_bib34","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1111\/apt.12324","article-title":"Review article: prescribing medications in patients with cirrhosis \u2013 a practical guide","volume":"37","author":"Lewis","year":"2013","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib35","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1038\/clpt.1983.14","article-title":"Acetaminophen in chronic liver disease","volume":"33","author":"Benson","year":"1983","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib36","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/hep.1840220312","article-title":"Acetaminophen (paracetamol) hepatotoxicity with regular intake of alcohol: analysis of instances of therapeutic misadventure","volume":"22","author":"Zimmerman","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.jceh.2014.03.049_bib37","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.jpainsymman.2012.06.019","article-title":"Do corticosteroids provide analgesic effects in cancer patients? A systematic literature review","volume":"46","author":"Paulsen","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jceh.2014.03.049_bib38","doi-asserted-by":"crossref","first-page":"ES39","DOI":"10.36076\/ppj.2012\/15\/ES39","article-title":"A\u00a0systematic review of randomized trials on the effectiveness of opioids for Cancer pain","volume":"15","author":"Koyyalagunta","year":"2012","journal-title":"Pain Physician"},{"key":"10.1016\/j.jceh.2014.03.049_bib39","first-page":"200","article-title":"Radiation hepatitis","volume":"93","author":"Ingold","year":"1965","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib40","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/0360-3016(92)90651-W","article-title":"The use of 3-D dose volume analysis to predict radiation hepatitis","volume":"23","author":"Lawrence","year":"1992","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2014.03.049_bib41","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s10585-011-9442-4","article-title":"Palliative radiation therapy for pulmonary metastases from hepatocellular carcinoma","volume":"29","author":"Jiang","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"10.1016\/j.jceh.2014.03.049_bib42","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1002\/1097-0142(19830301)51:5<863::AID-CNCR2820510520>3.0.CO;2-D","article-title":"Pathology of hepatocellular carcinoma in Japan","volume":"51","author":"Nakashima","year":"1983","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib43","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4143\/crt.2004.36.1.79","article-title":"Radioresponse of hepatocellular carcinoma-treatment of lymph node metastasis","volume":"36","author":"Yoon","year":"2004","journal-title":"Cancer Res Treat"},{"issue":"63","key":"10.1016\/j.jceh.2014.03.049_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.ijrobp.2005.03.058","article-title":"Consideration of role of radiotherapy for lymph node metastases in patients with HCC: retrospective analysis for prognostic factors from 125 patients","volume":"15","author":"Zeng","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.jceh.2014.03.049_bib45","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1111\/j.1478-3231.2005.01094.x","article-title":"Radiotherapy for painful bone metastases from hepatocellular carcinoma","volume":"25","author":"Seong","year":"2005","journal-title":"Liver Int"},{"key":"10.1016\/j.jceh.2014.03.049_bib46","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1111\/j.1572-0241.1998.00614.x","article-title":"Radiotherapy for osseous metastases from hepatocellular carcinoma: a retrospective study of 57 patients","volume":"93","author":"Kaizu","year":"1998","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jceh.2014.03.049_bib47","doi-asserted-by":"crossref","first-page":"2710","DOI":"10.1002\/cncr.24300","article-title":"Clinical features and prognostic factors in patients with bone metastases from hepatocellular carcinoma receiving external beam radiotherapy","volume":"115","author":"He","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib48","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/jjco\/hyl128","article-title":"A\u00a0retrospective study of radiotherapy for spinal bone metastases from hepatocellular carcinoma (HCC)","volume":"37","author":"Nakamura","year":"2007","journal-title":"Jpn J Clin Oncol"},{"issue":"5\u20136","key":"10.1016\/j.jceh.2014.03.049_bib49","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1159\/000113040","article-title":"Efficacy of percutaneous cementoplasty for bone metastasis from hepatocellular carcinoma","volume":"72","author":"Kodama","year":"2007","journal-title":"Oncology"},{"key":"10.1016\/j.jceh.2014.03.049_bib50","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1007\/s11060-008-9713-3","article-title":"Brain metastases from hepatocellular carcinoma: prognostic factors and outcome: brain metastasis from HCC","volume":"91","author":"Choi","year":"2009","journal-title":"J\u00a0Neurooncol"},{"key":"10.1016\/j.jceh.2014.03.049_bib51","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1080\/01635581.2012.675620","article-title":"Mini-nutritional assessment predicts functional status and quality of life of patients with hepatocellular carcinoma in Taiwan","volume":"64","author":"Hsu","year":"2012","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib52","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1038\/bjc.2012.92","article-title":"A\u00a0novel, externally validated inflammation-based prognostic algorithm in hepatocellular carcinoma: the prognostic nutritional index (PNI)","volume":"106","author":"Pinato","year":"2012","journal-title":"Br J Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib53","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJM199412083312303","article-title":"Perioperative nutritional support in patients undergoing hepatectomy for hepatocellular carcinoma","volume":"331","author":"Fan","year":"1994","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib54","first-page":"1525","article-title":"Long-term oral administration of branched chain amino acids after curative resection of hepatocellular carcinoma: a prospective randomized trial","volume":"84","year":"1997","journal-title":"Br J Surg"},{"issue":"11","key":"10.1016\/j.jceh.2014.03.049_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1046\/j.1440-1622.1999.01701.x","article-title":"Prospective randomized control study on the effect of branched-chain amino acids in patients with liver resection for hepatocellular carcinoma","volume":"69","author":"Meng","year":"1999","journal-title":"Aust N Z J Surg"},{"issue":"7","key":"10.1016\/j.jceh.2014.03.049_bib56","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1111\/j.1365-2036.2004.01920.x","article-title":"Long-term oral branched chain amino acids in patients undergoing chemoembolization for hepatocellular carcinoma: a randomized trial","volume":"19","author":"Poon","year":"2004","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib57","first-page":"A497","article-title":"Effects of supplementation with a branched-chain amino acid-enriched preparation on event-free survival and quality of life in cirrhotic patients with hepatocellular carcinoma. A multicenter, randomized controlled trial (Abstract)","volume":"130","author":"Kobashi","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jceh.2014.03.049_bib58","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.nutres.2008.12.005","article-title":"A\u00a0snack enriched with oral branched chain amino acids prevents a fall in albumin in patients with liver cirrhosis undergoing chemoembolization for hepatocellular carcinoma","volume":"29","author":"Takeshita","year":"2009","journal-title":"Nutr Res"},{"key":"10.1016\/j.jceh.2014.03.049_bib59","first-page":"CD008344","article-title":"Nutritional support for liver disease","volume":"5","author":"Koretz","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jceh.2014.03.049_bib60","first-page":"246","article-title":"Cancer: disease and nutrition are key determinants of patients\u2019 quality of life","volume":"12","author":"Ravasco","year":"2004","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib61","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1111\/j.1365-2036.2005.02628.x","article-title":"Review article: anorexia and cachexia in gastrointestinal cancer","volume":"22","author":"Ockenga","year":"2005","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jceh.2014.03.049_bib62","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1089\/jpm.2006.9.409","article-title":"Symptom control in palliative care\u2013part ii: cachexia\/anorexia and fatigue","volume":"9","author":"Del Fabbro","year":"2006","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib63","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jpainsymman.2003.09.007","article-title":"Systematic review of megestrol acetate in the treatment of anorexiacachexia syndrome","volume":"27","author":"Lopez","year":"2004","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jceh.2014.03.049_bib64","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejca.2005.07.026","article-title":"Prevention and treatment of cancer cachexia: new insights into an old problem","volume":"42","author":"Muscaritoli","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/j.jceh.2014.03.049_bib65","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1200\/JCO.2005.02.054","article-title":"Dietary counseling improves patient outcomes: a prospective, randomized, controlled trial in colorectal cancer patients undergoing radiotherapy","volume":"23","author":"Ravasco","year":"2005","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.jceh.2014.03.049_bib66","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1093\/jncimonographs\/lgh025","article-title":"Evidence-based treatment for cancer-related fatigue","volume":"32","author":"Mock","year":"2004","journal-title":"J\u00a0Natl Cancer Inst Monographs"},{"key":"10.1016\/j.jceh.2014.03.049_bib67","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1200\/JCO.2005.02.8506","article-title":"Patient-controlled methylphenidate for cancer fatigue: a double-blind, randomized, placebo-controlled trial","volume":"24","author":"Bruera","year":"2006","journal-title":"J\u00a0Clin Oncol"},{"issue":"2","key":"10.1016\/j.jceh.2014.03.049_bib68","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.amepre.2012.04.027","article-title":"Differential effects of exercise on cancer-related fatigue during and following treatment: a meta-analysis","volume":"43","author":"Puetz","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib69","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1177\/082585979300900204","article-title":"Results of antiemetic management in terminal illness","volume":"9","author":"Lichter","year":"1993","journal-title":"J\u00a0Palliat Care"},{"key":"10.1016\/j.jceh.2014.03.049_bib70","first-page":"348","article-title":"An assessment of aetiology-based guidelines for the management of nausea and vomiting in patients with advanced cancer","volume":"14","author":"Stephenson","year":"2006","journal-title":"Support Care Cancer"},{"issue":"1","key":"10.1016\/j.jceh.2014.03.049_bib71","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11894-004-0020-7","article-title":"Pruritus in chronic liver disease: mechanisms and treatment","volume":"6","author":"Bergasa","year":"2004","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/j.jceh.2014.03.049_bib72","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.jpainsymman.2012.02.008","article-title":"Randomized, double-blind, placebo-controlled trial of oral docusate in the management of constipation in hospice patients","volume":"45","author":"Tarumi","year":"2013","journal-title":"J\u00a0Pain Symptom Manage"},{"key":"10.1016\/j.jceh.2014.03.049_bib73","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1089\/jpm.2007.0178","article-title":"A\u00a0comparison of sennosides-based bowel protocols with and without docusate in hospitalized patients with cancer","volume":"11","author":"Hawley","year":"2008","journal-title":"J\u00a0Palliat Med"},{"key":"10.1016\/j.jceh.2014.03.049_bib74","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1097\/00007611-198402000-00020","article-title":"Therapeutic value of hope","volume":"77","author":"Bruhn","year":"1984","journal-title":"Southampt Med J"},{"key":"10.1016\/j.jceh.2014.03.049_bib75","doi-asserted-by":"crossref","first-page":"2898","DOI":"10.1001\/jama.285.22.2898","article-title":"Perspectives on care at the close of life. Psychological considerations, growth, and transcendence at the end of life: the art of the possible","volume":"285","author":"Block","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.jceh.2014.03.049_bib76","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/sj.bjc.6602949","article-title":"The effectiveness of treatment for depression\/depressive symptoms in adults with cancer: a systematic review","volume":"94","author":"Williams","year":"2006","journal-title":"Br J Cancer"}],"container-title":["Journal of Clinical and Experimental Hepatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0973688314002266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T06:02:07Z","timestamp":1760853727000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0973688314002266"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,8]]},"references-count":76,"alternative-id":["S0973688314002266"],"URL":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.049","relation":{},"ISSN":["0973-6883"],"issn-type":[{"value":"0973-6883","type":"print"}],"subject":[],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Role of Supportive Care for Terminal Stage Hepatocellular Carcinoma","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical and Experimental Hepatology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jceh.2014.03.049","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 INASL. Published by Elsevier, a division of Reed Elsevier India, Pvt. Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}